Agenda
10/01/2018 - 14:00 - Sala Charles Darwin

Understanding PARP1/2 inhibitor sensitivity in germline BRCA1/2 breast cancer and beyond


Scientific sessions

Violeta Serra

Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology. Barcelona